Health And Medicine
-
Drug discovery efforts may lead to new Rett syndrome treatments
Vanderbilt University research-ers have relieved symptoms of Rett syndrome in a mouse model with a small molecule that works like the dimmer switch in an electrical circuit. Read MoreAug 24, 2017
-
Oxidative stress on the brain
Vanderbilt investigators have discovered that oxidative damage may play an important role in the development of a rare cholesterol synthesis disease and in the behavioral changes of autism spectrum disorders. Read MoreAug 23, 2017
-
Fatty acids and adenoma risk
Vanderbilt researchers have found that red blood cell membrane fatty acid content is associated with risk of having colorectal adenomas, with omega-6 fatty acids increasing and omega-3 fatty acids decreasing risk. Read MoreAug 21, 2017
-
Sugars in human mother’s milk are non-toxic antibacterial agents
A new study has found that sugars in mother's' milk do not just provide nutrition for babies but also help protect them from bacterial infections. Read MoreAug 20, 2017
-
Predicting brain surgery outcomes
Assessing brain functional and structural connectivity in patients with temporal lobe epilepsy may be a useful way to identify the best candidates for surgical treatment. Read MoreAug 18, 2017
-
Block estrogen to treat lung disease
Based on findings from Vanderbilt investigators and others, clinical trials of estrogen inhibition for pulmonary arterial hypertension have recently been approved and funded by the National Institutes of Health. Read MoreAug 17, 2017
-
VUSN and VUMC researchers receive FAANP funding for Choosing Wisely collaborative study
A collaborative project between Vanderbilt University School of Nursing and Vanderbilt University Medical Center has received funding to pilot a project aimed at demonstrating the influence of nurse practitioners in reducing unnecessary testing. Read MoreAug 14, 2017
-
Stress may switch on bone “mets”
New findings could explain the link between chronic stress and reduced survival in women diagnosed with breast cancer, and could lead to new strategies to improve treatment outcomes. Read MoreAug 9, 2017
-
Early drivers of gastric cancer
Using bioinformatics approaches, Vanderbilt investigators have identified gene expression networks that are deregulated in mouse and human stomach cancers. Read MoreAug 8, 2017
-
New search committee for VBI director is appointed
A new committee has been named to lead a national search for the Barlow Family Director of the Vanderbilt Brain Institute. Read MoreAug 7, 2017
-
Vanderbilt begins Phase 1 trials of new Alzheimer’s drug
Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects. Read MoreAug 7, 2017
-
More than 120 undergrads gain graduate-level research experience through VSSA
Students hosted by the elite Vanderbilt Summer Science Academy presented their research—from stem cells to Zika—at the 15th annual Student Research Symposium held Aug. 3 at the Engineering and Science Building. Read MoreAug 4, 2017
-
An immune regulator of addiction
Although drug addiction is classically studied in a neuron-centric way, Vanderbilt researchers have discovered that the immune system also plays a critical role. Read MoreAug 4, 2017
-
Investigators match novel cancer mutations with potential therapies
Research led by Vanderbilt-Ingram Cancer Center (VICC) investigators may have solved a mystery about why a targeted therapy stops working in a small group of breast cancer patients. Read MoreAug 3, 2017
-
Researchers study unique couples intervention in Mozambique to reduce HIV transmission
Researchers in the Vanderbilt Institute for Global Health are testing whether a unique “couples-centered” intervention developed in the southern African nation of Mozambique can reduce mother-to-child transmission of HIV. Read MoreAug 3, 2017
-
HDAC3 role in B-cell development
The histone deacetylase HDAC3 is required for the maturation of B cells, white blood cells that produce antibodies. Read MoreAug 3, 2017
-
Investigators use light to kill microbial ‘vampires’
On July 24 Vanderbilt scientist Eric Skaar, Ph.D., MPH, summarized his group’s latest paper in a tweet: “If S. aureus is going to drink our blood like a vampire, let's kill it with sunlight.” Read MoreJul 27, 2017
-
Probing the genetics of autoimmunity
Vanderbilt researchers have found that non-coding regions of the genome appear to contribute to the risk of autoimmune diseases and may represent attractive therapeutic targets. Read MoreJul 21, 2017
-
Aspirnaut program helps launch students into science
Now in its ninth year, a unique summer research program at Vanderbilt University Medical Center (VUMC) designed primarily for rural students with limited resources is proving that talent has no zip code. Read MoreJul 20, 2017
-
Osher Center to study standards for mindfulness training
As mindfulness grows in popularity as a treatment option for conditions ranging from anxiety to chronic pain, experts in integrative medicine at Vanderbilt are doing research to better quantify its effectiveness and setting standards for how it is administered. Read MoreJul 20, 2017